Tongji-Ezhou Study
- Conditions
- Nutritional and Metabolic DiseasesMetabolic SyndromeRisk Factor, CardiovascularDiabetesCardiovascular DiseasesObesityEnvironmental Exposure
- Interventions
- Other: Dietary and environmental exposure (Observational study)
- Registration Number
- NCT03845868
- Lead Sponsor
- Huazhong University of Science and Technology
- Brief Summary
Tongji-Ezhou study (TJEZ) is a prospective cohort study launched at 2013 in EZhou city, Hubei province, with the goal of recruiting and assessing 10,000 individuals and then following them for at least 2 decades. In addition, blood samples would be collected every 3-5 years among 6000 of them to investigate the nutritional biomarkers and potential determinants of chronic diseases such as obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 10000
- (i) permanent residence in Ezhou district (minimum of 9 months); (ii) written informed consent; (iii) age ≥ 20 years old at the time of enrolling in the study.
- (i) with chemotherapy or radiotherapy for cancer and other severe diseases.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Ezhou CDC physical examination center Dietary and environmental exposure (Observational study) - Egang hospital physical examination center Dietary and environmental exposure (Observational study) -
- Primary Outcome Measures
Name Time Method Diabetic complications mean follow up of 10 years Development of diabetic complications
Incidence of diabetes 5 years Type 2 diabetes was diagnosed when FPG ≥ 7.0 mmol/L and/or OGTT2h ≥ 11.1 mmol/L, or using diabetic medication (self-report).
Incidence of metabolic syndrome 5 years Metabolic syndrome is defined as using the updated National Cholesterol Education Program/Adult Treatment Panel III criteria for Asian Americans. These criteria require three or more of the following components: (1) central obesity (waist circumference of ≥90 cm for men or ≥80 cm for women), (2) triglycerides of ≥1.7 mmol/L, (3) HDL-C of \<1.03 mmol/L for men or \<1.30 mmol/L for women, (4) blood pressure of ≥130/85 mmHg or on medication for hypertension, and (5) fasting glucose of ≥5.6 mmol/L.
Incidence of cardiovascular diseases mean follow up of 10 years Cardiovascular death, stroke, myocardial infarction, heart failure
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Huazhong University of Science and Technology
🇨🇳Wuhan, Hubei, China